upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminohapete ainevahetus, kaasasündinud vead - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
beyfortus
astrazeneca ab - nirsevimab - suguhormoonid ja immunoglobuliinid, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosupressandid - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
vetemex süstelahus
cp-pharma handelsgesellschaft mbh - maropitant - süstelahus - 10mg 1ml 20ml 1tk; 10mg 1ml 10ml 1tk; 10mg 1ml 50ml 1tk; 10mg 1ml 25ml 1tk
dutasteride inteli pehmekapsel
inteli generics nord uab - dutasteriid - pehmekapsel - 0,5mg 60tk; 0,5mg 90tk; 0,5mg 50tk; 0,5mg 10tk; 0,5mg 30tk
hesio õhukese polümeerikattega tablett
zentiva k.s. - diosmiin+hesperidiin - õhukese polümeerikattega tablett - 900mg+100mg 30tk; 900mg+100mg 60tk; 900mg+100mg 18tk; 900mg+100mg 36tk
camzyos
bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - muud kardiaalsed preparaadid - treatment of symptomatic obstructive hypertrophic cardiomyopathy.
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratoorsed süntsüütilised viirusinfektsioonid - vaktsiinid - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
vominil süstelahus
vetviva richter gmbh - maropitant - süstelahus - 10mg 1ml 25ml 1tk; 10mg 1ml 10ml 5tk; 10mg 1ml 50ml 1tk
arocenia süstelahus
krka d.d. novo mesto - maropitant - süstelahus - 10mg 1ml 20ml 1tk